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Department of Dermatology, School of Medicine, University of Oregon Health Sciences Center, Portland, 
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Accumulations of neutrophilic granu locytes within the epidermis and beneath the stratum 
corneum of the skin are a prominent histologic feature of experimental and clinical 
candidiasis. The mechanism of ce ll accumulation was studied by standard chemotactic 
methods. Suspensions of viable or heat-killed Candida sp caused marked chemotaxis of 
human neut rophils in fresh serum. Culture supernatants of Candida sp were not chemotac-
tic. Chemotaxis was dependent upon fresh serum, and could be abolished by heating the 
serum to 56°C for 30 min, suggesting that interaction of these organisms with a heat- labile 
serum factor generated a chemoattractant. 
Incubation of Candida sp with fresh human serum resulted in the conversion of the third 
component of complement and properdin factor B, as measured by immunoelectrophoresis. 
Conversion did not occur in serum chelated with EDTA, or heated to 50°C for 30 min (to 
destroy factor B) . Conversion was present in serum chelated with EGTA (to deplete 
. calcium) , or genetically deficient in the fourth component of complement. By contrast, the 
three components of the kinin-forming system (Hageman factor , prekallikrein, high-molecu-
lar-weight kininogen) were not activated by Candida sp. 
We suggest that Candida sp do not release a chemotactic substance but, in t he presence of 
serum, activate the alternative pathway of complement, generating chemotactic factors. 
Experimental studies of cutaneous candidiasis 
in man [1, 2 ] and rodents [3] have reproduced the 
histopathologic feature of leukocytic su bcorneal 
pustules, yet the pathophysiology of t his cell accu-
mulation remains unknown . Two mechanisms 
have been proposed . The first [1] suggests the 
release of tox ic substances by the organism, which 
evokes a primary irritant type dermatitis. The 
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NHS: norm al hum an serum 
PMN: polymorp honuclear 
VB: veronal buffer 
second [3 ] proposes that Candida sp activate 
serum complement, resulting in t he generation of 
potent chemoattractants. Here we describe an in 
vitro study of Candida albicans-induced leukocyte 
chemotaxis, and show this migration to be depend-
ent on a heat-labile serum factor . Immunochemi-
cal evidence of alternative (properdin) pathway 
complement activation by Candida sp is pre-
sented. We propose that the acute subcorneal 
pustular reaction in cutaneous candidiasis is not 
an irritant dermatitis to toxic substances, but an 
inflammatory response to chemotactic factors gen-
erated by the a lternative pathway activation of 
complement by Candida sp. 
MATERIALS AND METHODS 
Preparation of Candida cultures and suspensions . 
Three stra ins of C. albicans and one of C. tropicalis were 
obtained from human sources, identified by sugar ass imi-
lation a nd fermentation [4), and maintained on Sabou-
raud agar at room temperature. 
Concentration and viabi lity of organisms were deter-
mined by cell counts on a Neubauer hemocytometer 
using Trypan blue dye at a fin al concentration of 0.08%. 
Greater t han 95% of t he organisms were viable blasto-
spores. Heat-killed organisms were produced by auto -
cl aving Sabouraud broth cultures at 125°C at 15 lbs/sq 
in. for 20 min ; they took up trypan blue dye and were 
sterile on su bsequent culture. 
Suspensions 01' Candida for activation of serum com-
plement were prepared by t riple washing viable or 
heat-k illed broth cultures in 0.05 M sodium veronal buffer 
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(VB), pH 8.6, and adjusting the concentration to 1 X 10' 
organisms per ml VB. Similar suspens ions, prepared in 
normal saline, pH 7.3, were used to study kinin activa-
tion. 
N e utrophil chemotaxis . In vitro chemotaxis was per· 
formed according to Ward [5] with some modifications. 
Modified Boyden chemotax is chambers (AHLCO Mfg. 
Co .. New Britain, Conn.) were used with 3. 0-1l Millipore 
filters (SSWP02500, Millipore Filter Corp., Bedford, 
Mass.). Human polymorphonuclear (PMN) cells were 
obtained from normal venipuncture whole blood by 
Bypaque-Ficol grad ient and dextran sedimentation [6], 
washed 3 t imes and suspended in 0.02 M Tris-buffered 
Medium 199 alone, with 10% homologous or heat-inac-
tivated (56°C for 30 min) serum at pH 7.4 at a concentra-
tion of 3 X 10' PMN per ml. Test solu t ions were viable or 
heat-killed C. albicans in Medium 199,2 x 10' organisms 
per m l, Sabouraud broth culture supernatants, and 
Medium 199 cul ture supernatants. Control solu tions were 
Medium 199 or Sabouraud broth. One milliliter of PMN 
cell suspension and 1 ml of test solution were placed in 
the top and bottom chambers of the Boyden chamber 
respectively, and incubated at 37°C for 3 hr. The filter 
was then removed, stained [7], and exam ined under light 
rnicroscopy, counting 5 random high-power fields (HPF) 
for migrating PMN cells. The average number of PMN 
cells w as determined in 10 HPF, from duplicate tests. 
Activation of serum complement. Fresh normal hum an 
serum (NHS) was used, either undiluted or chelated by 
the addition of 1/10 volume 0.1 M ethyleneglycol-bis-(.B-
amino·ethyl ether)N,N'-tetraacetic acid (EGTA) or 0.1 M 
ethylenediamine tetraacetic acid (EDTA) in VB. Neither 
chela ted serum would support hemolys is when mixed 
with sensitized sheep red blood cells. Factor B·depleted 
serum was prepared by heating NHS to 50°C for 30 min. 
This serum, in immunoelectrophoresis (IEP) against 
antifactor B, produced one gamma-m igrating precipitin 
line. Zymosan (Sigma Chemical Co., St. Louis, Mo'.), 15 
rng/ml in VB, was used as a positive control for activation 
of complement. Sixty microliters of C. albicans, C. 
tropicalis, or zymosan suspension were mixed with 250 III 
of NHS, factor B-depleted serum, or 275 III of EDTA or 
EGT A chela ted serum, and incubated at 37°C for 1 hr 
with f requent agitation . The reaction mixture was che-
lated with 1/10 volume of 0.1 M EDTA in VB, and 
centrifuged at 3,000 rpm for 10 min. The supernatant was 
analyzed by IEP against anti hum an C3 ({31C/{31A) and 
antihuman factor B. 
Immunoelectrophoresis. IEP was performed on micro-
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scope slides us ing 2% ion agar #2 (Colab, Oxoid Ion Agar 
#2, Chicago Heights, TIl.) or 2% purified agar (Behring 
Diagnostics purified agar, American Hoechst Corp., 
Woodbury, N. Y.) in 0.01 M EDTA VB with a continuous 
potential grad ient of 6 volts/cm for 2 hr at 4°C. 
Antisera . Goat antisera to human C3 ({31C/{31A) and 
rabbit antisera tv human properdin factor B (C3 activa-
tor) were purchased (Behring Diagnostics, American 
Hoechst Corp., Woodbury, N.Y.), and each gave one 
precipitin line when analyzed by double diffusion in agar 
against NHS. 
Assessment of plasma kinin-forming system. C. albi-
cans or C. tropicalis (1 x 10' organisms/m l) in normal 
saline were incubated at a dilution of 1/4 (v/v) in a pool of 
norm al plasma from 28 individuals at 37°C for 60 min. 
Consumption of components of t he kinin-forming system 
was assessed by measuring the capacity of treated normal 
plasma to correct t he activated partial thromboplastin 
t ime of plasma deficient in Hageman factor, prekallikrein 
(F letcher factor) [8], or high-molecular-weight (HMW) 
kininogen (Flaujeac factor) [9]. Untreated normal 
plasma, tested upon thawing from - 70°C and ' after 
incubation at 3°C for 60 min served as control. The 
results were measured as percent factor remaining. 
RESULTS 
Leukocyte chemotaxis. Chemotaxis test results 
are presented in Table I as the average number of 
cells per high-powered field. Viable or heat-killed 
C. albicans evoked brisk leukocyte migration 
across the Millipore filter of the chemotactic cham-
ber. This migration was dependent on the presence 
of serum within the system, and could be abolished 
by preheating the serum to 56°C for 30 min. 
Supernatants of Candida cultures grown in Sabou-
raud broth or Medium 199 were not chemotactic 
nor were the respective cu lture media alone. Can-
ditl a gr:owth and differentiation were. unimpaired 
by this system', since hyphae and germ tube 
formation were evident in viable suspensions. 
Complement activation. Incubation of viable or 
heat-killed C. albicans or C. tropicalis in NHS 
resulted in the immunoelectrophoretic conversion 
of C3 from {31C to {31A, and factor B from {32 
mobility to 'Y mobility. The Figure illustrates these 
conversions. The activation of complement was 
TABLE I. Leukocyte chemotaxis by Candida albicans 
Attractant 
C. albicans viable 
C. albicans heat-killed 
C. albicans viable 
C. albicans heat-ki lled 
C. al bicans viable 
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FIG. Immunoelectrophoretic conversion of C3 a!1d fac-
tor B. A = normal human serum; B = CandIda sp-
treated human serum. The upper panel shows the 
conversion of C3 from IHC (A) to rnA (B) mobility, and 
t he lower panel shows the conversion of factor B from fJ2 
(A) to 'Y (B) mobility. 
TABLE II. Alternative pathway activation of complement 
by Candida albicans 
C. albicans + NHS 
C. albicans + NHS + 0.01 
EGTA 
C. albicans + NHS + 0.01 
EDTA 
C. albicans + factor B-de-
pleted serum (50°C X 30 
min) 
C. albicans + C4-deficient 
serum 
C. albicans heat-killed + NHS 
C. tropicalis + NHS 










EGTA = ethyleneglycol tetra acetic acid 









abolished in 10 mM EDTA chelated serum, or 
serum heated to 50°C or 56°C for 30 min. Comple-
ment conversion was not abolished in serum che-
lated with 10 mM EGTA, or human serum geneti-
cally deficient in C4. These results are summarized 
in Table ll. 
Kinin-forming system. Incubation of normal 
pooled human plasma with C. qlbicans or C. 
tropicalis failed to deplete the components of the 
kinin-forming system. Pooled normal plasma (N = 
28) was tested upon t hawing from - 70°C, after 
incubation at 37°C for 60 min, or after incubation 
with Candida sp under the same conditions. There 
was no consumption of plasma Hageman factor, 
prekallikrein, or HMW-kininogen during incuba-
tion with Candida sp . 
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DISCUSSION 
The histologic hallmark of cutaneous candidasis 
is the neutrophilic, subcorneal, and intraepidermal 
pustule. The emigration of inflammatory cells 
from dermal blood vessels to epidermal sites of 
Candida infection suggests the presence of a che-
moattractant. Human experimental studies [1] 
propose that Candida-generated irritant products, 
associated with the cell bodies, produce a contact 
dermatitis of the primary irritant type. An alterna-
tive hypothesis would be the interaction of Can-
dida with endogenous mediators of inflammation, 
such as the serum complement, or the plasma 
kinin-forming systems. 
Several inflammatory responses to Candida sp 
have been associated with heat-labile humoral 
factors, suggesting the participation of endogenous 
mediators. Leukocyte killing of C. albicans has 
been studied in vitro by Davies and Denning [10] 
and found to be dependent on a plasma factor. 
This candidacidal activity could be inhibited by 
heating plasma to 56°C for 30 min,_ treating it with 
zymosan, or a cell wall-enriched fraction of C. 
albicans. Lehrer and Cline [11] found that neutro-
phil phagocytosis of Candida cells was accelerated 
by heat-labile serum factors. 
Subsequently, Denning and Davies [12] reported 
positive chemotaxis of neutrophils towards suspen-
sions of C. albicans, which could be abolished by 
heating serum to 56°C, and was directly propor-
tional to the surface area of the microbial mass. 
Candida blastospores attracted significantly more 
neutrophils than mycelium. Furthermore, a cell 
wall mannan preparation produced marked leuko-
cyte migration. They suggested that Candida cell 
wall mannan reacts with serum complement to 
generate a chemotactic agent. 
The chemotaxis studies reported here confirm 
that Candida-induced PMN leukocyte migration is 
dependent on heat-labile serum factors, and inde-
pendent of Candida viability. Furthermore, Can-
dida culture supernatants possess no chemoat-
tractant activity, which argues against an exotoxin 
product of Candida. Immunoelectrophoretic stud-
ies presented here clearly show Candida sp activa-
tion of complement via the alternative pathway. 
Complement activation occurs by at least two 
distinct pathways. The calcium- and magnesium-
dependent classical pathway is activated by 
antigen-antibody complexes, while the magnesi-
um-dependent alternative pathway is activated by 
immunoglobulin, lipopolysaccharides, and zymo-
san. EDTA chelates calcium and magnesium, and 
prevents activation of both pathways, while EGTA 
preferentially binds calcium, blocking the classical 
pathway but leaving the alternative pathway 
intact [13,14]. 
Immunoelectrophoretic analysis of serum after 
incubation with Candida revealed conversion of 
two complement components, C3 and factor B. To 
determine whether activation was by classical or 
alternative pathways, serum chelating studies 
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were done. As summarized in Table II, EDTA-
chelated serum abolished conversion of both C3 
and factor B, while EGTA-chelated serum sup-
ported conversion of both factors. Furthermore, 
heat inactivation of alternative pathway factor B 
abolished C3 activation, suggesting that the classi-
cal pathway is not operative. Finally, serum genet-
ically deficient in the fourth component of comple-
lllent, C4, supported conversion of both C3 and 
factor B. These data conclusively show that Can-
dida activation of complement occurs via the 
alternative pathway, independent of the classical 
pathway. 
The activation of complement generates several 
chelllotactic principles which attract neutrophils, 
C3a, C5a, and the trimolecular complex C5,6,7. 
Several microbial organisms activate complement 
via the alternative pathway, including the yeast S. 
cervisiae, whose boiled cell wall preparation is 
called zymosan. Candida activation of com ple-
lllent appears analogous to zymosan, and may be a 
property of the Candida cell wall mannan. 
Complement activation is not unique to C. 
albicans, since both viable and heat-killed C. 
tropicalis activate C3 and factor B. C. tropicalis in 
a rodent model of cutaneous candidiasis does not 
produce lesions [3 ], suggesting that complement 
activation is not restricted to the more common 
opportunistic species of Candida. 
The alternative pathway activation of com ple-
lllent generates several active mediators of inflam-
mation. Among these are opsonins, anaphylatox-
ins, and chemoattractants which enhance the 
directional migration and phagocytic function of 
neu trophils, ultimately enhancing the killing of the 
yeast celL 
A separate system of inflammatory mediators 
exists in plasma, the kinin-forming system. It is 
cOlllposed of Hageman factor, prekallikrein, and 
kininogen. The failure of Candida to consume 
these factors when incubated in normal plasma is 
evidence against the direct participation of the 
kinin system in the acute inflammation of can-
didiasis. 
Studies of experimental candidiasis in rodents 
suggest that the acute pustular inflammatory re-
sponse is associated with hyphal penetration of the 
viable epidermis. Candida cell wall contact with 
serum proteins would activate the complement cas-
cade, generating opsonins and chemoattractants. 
The emigration of neutrophils in response to this 
stimulus would ultimately lead to subcorneal mi-
croabscesses of leukocytes. In rodents, neutrophils 
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accumulate about hyphal processes, wherever they 
penetrate the stratum corneum into the viable 
malpighian layer of the epidermis. We have re-
cently found that cobra venom factor depletion of 
complement in rodents will inhibit this response 
[15], further supporting the hypothesis of comple-
ment-induced inflammation. 
We are grateful for the technical assistance of Ms. 
Cinda Lobitz and greatly appreciative of Dr. Hans Ochs, 
University of Washington, Seattle, Washington, who 
provided us with serum deficient in C4. 
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